GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BATM Advanced Communications Ltd (OTCPK:BVCLF) » Definitions » Cash Conversion Cycle

BATM Advanced Communications (BATM Advanced Communications) Cash Conversion Cycle : 102.20 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is BATM Advanced Communications Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

BATM Advanced Communications's Days Sales Outstanding for the six months ended in Dec. 2023 was 81.57.
BATM Advanced Communications's Days Inventory for the six months ended in Dec. 2023 was 157.83.
BATM Advanced Communications's Days Payable for the six months ended in Dec. 2023 was 137.2.
Therefore, BATM Advanced Communications's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 102.20.


BATM Advanced Communications Cash Conversion Cycle Historical Data

The historical data trend for BATM Advanced Communications's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BATM Advanced Communications Cash Conversion Cycle Chart

BATM Advanced Communications Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.53 74.21 110.25 135.62 134.61

BATM Advanced Communications Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.38 106.24 112.59 108.57 102.20

Competitive Comparison of BATM Advanced Communications's Cash Conversion Cycle

For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BATM Advanced Communications's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where BATM Advanced Communications's Cash Conversion Cycle falls into.



BATM Advanced Communications Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

BATM Advanced Communications's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=70.44+159.94-95.77
=134.61

BATM Advanced Communications's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=81.57+157.83-137.2
=102.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BATM Advanced Communications  (OTCPK:BVCLF) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


BATM Advanced Communications Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of BATM Advanced Communications's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


BATM Advanced Communications (BATM Advanced Communications) Business Description

Traded in Other Exchanges
Address
4 Ha’harash Street, P.O.B. 7318, Nave Ne'eman Industrial Area, Hod Hasharon, ISR, 4524075
BATM Advanced Communications Ltd is an Israel-based technology company. The company organizes its business operations into two divisions: Networking & Cyber Division and Biomedical Division. Networking and Cyber Division mostly includes the research and development, production, and marketing of data communication products in the field of local and wide area networks and premises management systems. Bio-Medical Division is engaged in the research and development, production, marketing, and distribution of medical products, primarily laboratory diagnostic equipment and sterilization equipment. The majority of its revenue is derived from Biomedical Division. Its geographical segments are the United States of America, Israel, and Europe.